Synektik, a leading manufacturer of advanced radiopharmaceutical products and IT solutions, intends to continue the positive trends in its performance, with a focus on geographical expansion and product offensive. As noted by Dariusz Korecki, the company’s deputy CEO, the main growth driver will be recurring revenue, the growth of which is expected to increase from the current 37 percent to more than 50 percent in two years’ time. According to Korecki, in early 2025 Synektik will also start operations in the Baltics after the group extended its cooperation with Intuitive Surgical to market the da Vinci Surgical System in Lithuania, Latvia and Estonia. (ICE VARSAVIA)

Fonte notizia: Pakiet